Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Aug 2;155(3):137-44.
doi: 10.7326/0003-4819-155-3-201108020-00003.

Population-based risk for complications after transthoracic needle lung biopsy of a pulmonary nodule: an analysis of discharge records

Renda Soylemez Wiener  1 , Lisa M Schwartz, Steven Woloshin, H Gilbert Welch
Affiliations

Population-based risk for complications after transthoracic needle lung biopsy of a pulmonary nodule: an analysis of discharge records

Renda Soylemez Wiener et al. Ann Intern Med. .

Abstract

Background: Because pulmonary nodules are found in up to 25% of patients undergoing computed tomography of the chest, the question of whether to perform biopsy is becoming increasingly common. Data on complications after transthoracic needle lung biopsy are limited to case series from selected institutions.

Objective: To determine population-based estimates of risks for complications after transthoracic needle biopsy of a pulmonary nodule.

Design: Cross-sectional analysis.

Setting: The 2006 State Ambulatory Surgery Databases and State Inpatient Databases for California, Florida, Michigan, and New York from the Healthcare Cost and Utilization Project.

Patients: 15 865 adults who had transthoracic needle biopsy of a pulmonary nodule.

Measurements: Percentage of biopsies complicated by hemorrhage, any pneumothorax, or pneumothorax requiring a chest tube, and adjusted odds ratios for these complications associated with various biopsy characteristics, calculated by using multivariate, population-averaged generalized estimating equations.

Results: Although hemorrhage was rare, complicating 1.0% (95% CI, 0.9% to 1.2%) of biopsies, 17.8% (CI, 11.8% to 23.8%) of patients with hemorrhage required a blood transfusion. In contrast, the risk for any pneumothorax was 15.0% (CI, 14.0% to 16.0%), and 6.6% (CI, 6.0% to 7.2%) of all biopsies resulted in pneumothorax requiring a chest tube. Compared with patients without complications, those who experienced hemorrhage or pneumothorax requiring a chest tube had longer lengths of stay (P < 0.001) and were more likely to develop respiratory failure requiring mechanical ventilation (P = 0.020). Patients aged 60 to 69 years (as opposed to younger or older patients), smokers, and those with chronic obstructive pulmonary disease had higher risk for complications.

Limitations: Estimated risks may be inaccurate if coding of complications is incomplete. The analyzed databases contain little clinical detail (such as information on nodule characteristics or biopsy pathology) and cannot indicate whether performing the biopsy produced useful information.

Conclusion: Whereas hemorrhage is an infrequent complication of transthoracic needle lung biopsy, pneumothorax is common and often necessitates chest tube placement. These population-based data should help patients and physicians make more informed choices about whether to perform biopsy of a pulmonary nodule.

Primary funding source: Department of Veterans Affairs and National Cancer Institute.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Inclusion and exclusion criteria to create final study population
*Includes open or video-assisted thoracosopic surgical biopsy, excision, wedge resection, segmentectomy, lobectomy, or pneumonectomy
Figure 2
Figure 2. Adjusted risk of complications following transthoracic needle biopsy of a pulmonary nodule
*Adjusted for all variables shown in Table 3 using generalized estimating equations models.
See this image and copyright information in PMC

Comment in

References

    1. Ost D, Fein AM, Feinsilver SH. Clinical practice. The solitary pulmonary nodule. N Engl J Med. 2003;348(25):2535–42. - PubMed
    1. Gould MK, Fletcher J, Iannettoni MD, Lynch WR, Midthun DE, Naidich DP, et al. Evaluation of patients with pulmonary nodules: when is it lung cancer?: ACCP evidence-based clinical practice guidelines. Chest. (2nd edition) 2007;132(3 Suppl):108S–30S. - PubMed
    1. The Dartmouth Atlas of Health Care. Oct 15, 2010.
    1. Geraghty PR, Kee ST, McFarlane G, Razavi MK, Sze DY, Dake MD. CT-guided transthoracic needle aspiration biopsy of pulmonary nodules: needle size and pneumothorax rate. Radiology. 2003;229(2):475–81. - PubMed
    1. Covey AM, Gandhi R, Brody LA, Getrajdman G, Thaler HT, Brown KT. Factors associated with pneumothorax and pneumothorax requiring treatment after percutaneous lung biopsy in 443 consecutive patients. J Vasc Interv Radiol. 2004;15(5):479–83. - PubMed

Publication types

MeSH terms